Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Miki

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
Anticancer Research|August 19, 2007
Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727Katsuhiko Ono, Takashi Suzuki, Yasuhiro Miki, et al.
The Tohoku Journal of Experimental Medicine|November 2, 2006
Expression profiles of sex steroid receptors in desmoid tumorsMasato Ishizuka, Masahito Hatori, Osamu Dohi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 15, 2011
LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancerMinako Sakurai, Yasuhiro Miki, Mariko Masuda, et al.
Endocrine Journal|February 5, 2016
Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migrationKiyoshi Takagi, Yasuhiro Miki, Sota Tanaka, et al.
Histology and Histopathology|June 1, 2019
Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinomaAi Sato, Kiyoshi Takagi, Yasuhiro Miki, et al.
The Journal of Endocrinology|June 19, 2014
Expression of steroidogenic enzymes in human sebaceous glandsTakayoshi Inoue, Yasuhiro Miki, Shingo Kakuo, et al.
International Journal of Breast Cancer|April 17, 2026
T-Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast CarcinomaMio Yamaguchi-Tanaka, Kiyoshi Takagi, Mai Sawafuji, et al.
Cancers|January 8, 2025
Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type IAi Sato, Kiyoshi Takagi, Momoka Yoshida, et al.
Plos One|May 30, 2009
Genetic characterization of type A enterotoxigenic Clostridium perfringens strainsAgi Deguchi, Kazuaki Miyamoto, Tomomi Kuwahara, et al.
Cancer Science|January 22, 2009
Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expressionShuji Nagasaki, Takashi Suzuki, Yasuhiro Miki, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
Anticancer Research|August 19, 2007
Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727Katsuhiko Ono, Takashi Suzuki, Yasuhiro Miki, et al.
The Tohoku Journal of Experimental Medicine|November 2, 2006
Expression profiles of sex steroid receptors in desmoid tumorsMasato Ishizuka, Masahito Hatori, Osamu Dohi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 15, 2011
LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancerMinako Sakurai, Yasuhiro Miki, Mariko Masuda, et al.
Endocrine Journal|February 5, 2016
Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migrationKiyoshi Takagi, Yasuhiro Miki, Sota Tanaka, et al.
Histology and Histopathology|June 1, 2019
Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinomaAi Sato, Kiyoshi Takagi, Yasuhiro Miki, et al.
The Journal of Endocrinology|June 19, 2014
Expression of steroidogenic enzymes in human sebaceous glandsTakayoshi Inoue, Yasuhiro Miki, Shingo Kakuo, et al.
International Journal of Breast Cancer|April 17, 2026
T-Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast CarcinomaMio Yamaguchi-Tanaka, Kiyoshi Takagi, Mai Sawafuji, et al.
Cancers|January 8, 2025
Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type IAi Sato, Kiyoshi Takagi, Momoka Yoshida, et al.
Plos One|May 30, 2009
Genetic characterization of type A enterotoxigenic Clostridium perfringens strainsAgi Deguchi, Kazuaki Miyamoto, Tomomi Kuwahara, et al.
Cancer Science|January 22, 2009
Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expressionShuji Nagasaki, Takashi Suzuki, Yasuhiro Miki, et al.
Pageof 23